1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Oncolytic Virus Immunotherapy Revenue
• 1.4 Market by Type
  • 1.4.1 Global Oncolytic Virus Immunotherapy Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Engineering Oncolytic Viruses
  • 1.4.3 Wild-Type Oncolytic Viruses
• 1.5 Market by Application
  • 1.5.1 Global Oncolytic Virus Immunotherapy Market Share by Application: 2020 VS 2026
  • 1.5.2 Hospitals
  • 1.5.3 Clinics
  • 1.5.4 Ambulatory Surgical Centers
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global Oncolytic Virus Immunotherapy Market Perspective (2015-2026)
• 2.2 Global Oncolytic Virus Immunotherapy Growth Trends by Regions
  • 2.2.1 Oncolytic Virus Immunotherapy Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Oncolytic Virus Immunotherapy Historic Market Share by Regions (2015-2020)
  • 2.2.3 Oncolytic Virus Immunotherapy Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Oncolytic Virus Immunotherapy Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Oncolytic Virus Immunotherapy Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Oncolytic Virus Immunotherapy Players by Market Size
  • 3.1.1 Global Top Oncolytic Virus Immunotherapy Players by Revenue (2015-2020)
  • 3.1.2 Global Oncolytic Virus Immunotherapy Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Oncolytic Virus Immunotherapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Oncolytic Virus Immunotherapy Market Concentration Ratio
  • 3.2.1 Global Oncolytic Virus Immunotherapy Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Oncolytic Virus Immunotherapy Revenue in 2019
• 3.3 Oncolytic Virus Immunotherapy Key Players Head office and Area Served
• 3.4 Key Players Oncolytic Virus Immunotherapy Product Solution and Service
• 3.5 Date of Enter into Oncolytic Virus Immunotherapy Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Oncolytic Virus Immunotherapy Historic Market Size by Type (2015-2020)
• 4.2 Global Oncolytic Virus Immunotherapy Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global Oncolytic Virus Immunotherapy Market Size by Application (2015-2020)
• 5.2 Global Oncolytic Virus Immunotherapy Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Oncolytic Virus Immunotherapy Market Size (2015-2020)
• 6.2 Oncolytic Virus Immunotherapy Key Players in North America (2019-2020)
• 6.3 North America Oncolytic Virus Immunotherapy Market Size by Type (2015-2020)
• 6.4 North America Oncolytic Virus Immunotherapy Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Oncolytic Virus Immunotherapy Market Size (2015-2020)
• 7.2 Oncolytic Virus Immunotherapy Key Players in Europe (2019-2020)
• 7.3 Europe Oncolytic Virus Immunotherapy Market Size by Type (2015-2020)
• 7.4 Europe Oncolytic Virus Immunotherapy Market Size by Application (2015-2020)

8 China

• 8.1 China Oncolytic Virus Immunotherapy Market Size (2015-2020)
• 8.2 Oncolytic Virus Immunotherapy Key Players in China (2019-2020)
• 8.3 China Oncolytic Virus Immunotherapy Market Size by Type (2015-2020)
• 8.4 China Oncolytic Virus Immunotherapy Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Oncolytic Virus Immunotherapy Market Size (2015-2020)
• 9.2 Oncolytic Virus Immunotherapy Key Players in Japan (2019-2020)
• 9.3 Japan Oncolytic Virus Immunotherapy Market Size by Type (2015-2020)
• 9.4 Japan Oncolytic Virus Immunotherapy Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Oncolytic Virus Immunotherapy Market Size (2015-2020)
• 10.2 Oncolytic Virus Immunotherapy Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Oncolytic Virus Immunotherapy Market Size by Type (2015-2020)
• 10.4 Southeast Asia Oncolytic Virus Immunotherapy Market Size by Application (2015-2020)

11 India

• 11.1 India Oncolytic Virus Immunotherapy Market Size (2015-2020)
• 11.2 Oncolytic Virus Immunotherapy Key Players in India (2019-2020)
• 11.3 India Oncolytic Virus Immunotherapy Market Size by Type (2015-2020)
• 11.4 India Oncolytic Virus Immunotherapy Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Oncolytic Virus Immunotherapy Market Size (2015-2020)
• 12.2 Oncolytic Virus Immunotherapy Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Oncolytic Virus Immunotherapy Market Size by Type (2015-2020)
• 12.4 Central & South America Oncolytic Virus Immunotherapy Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Merck
  • 13.1.1 Merck Company Details
  • 13.1.2 Merck Business Overview
  • 13.1.3 Merck Oncolytic Virus Immunotherapy Introduction
  • 13.1.4 Merck Revenue in Oncolytic Virus Immunotherapy Business (2015-2020))
  • 13.1.5 Merck Recent Development
• 13.2 Amgen
  • 13.2.1 Amgen Company Details
  • 13.2.2 Amgen Business Overview
  • 13.2.3 Amgen Oncolytic Virus Immunotherapy Introduction
  • 13.2.4 Amgen Revenue in Oncolytic Virus Immunotherapy Business (2015-2020)
  • 13.2.5 Amgen Recent Development
• 13.3 TILT Biotherapeutics
  • 13.3.1 TILT Biotherapeutics Company Details
  • 13.3.2 TILT Biotherapeutics Business Overview
  • 13.3.3 TILT Biotherapeutics Oncolytic Virus Immunotherapy Introduction
  • 13.3.4 TILT Biotherapeutics Revenue in Oncolytic Virus Immunotherapy Business (2015-2020)
  • 13.3.5 TILT Biotherapeutics Recent Development
• 13.4 Oncorus
  • 13.4.1 Oncorus Company Details
  • 13.4.2 Oncorus Business Overview
  • 13.4.3 Oncorus Oncolytic Virus Immunotherapy Introduction
  • 13.4.4 Oncorus Revenue in Oncolytic Virus Immunotherapy Business (2015-2020)
  • 13.4.5 Oncorus Recent Development
• 13.5 Sorrento Therapeutics
  • 13.5.1 Sorrento Therapeutics Company Details
  • 13.5.2 Sorrento Therapeutics Business Overview
  • 13.5.3 Sorrento Therapeutics Oncolytic Virus Immunotherapy Introduction
  • 13.5.4 Sorrento Therapeutics Revenue in Oncolytic Virus Immunotherapy Business (2015-2020)
  • 13.5.5 Sorrento Therapeutics Recent Development
• 13.6 Shanghai Sunway Biotech
  • 13.6.1 Shanghai Sunway Biotech Company Details
  • 13.6.2 Shanghai Sunway Biotech Business Overview
  • 13.6.3 Shanghai Sunway Biotech Oncolytic Virus Immunotherapy Introduction
  • 13.6.4 Shanghai Sunway Biotech Revenue in Oncolytic Virus Immunotherapy Business (2015-2020)
  • 13.6.5 Shanghai Sunway Biotech Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer

Oncolytic Virus Immunotherapy market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Oncolytic Virus Immunotherapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Merck
Amgen
TILT Biotherapeutics
Oncorus
Sorrento Therapeutics
Shanghai Sunway Biotech
...

Market segment by Type, the product can be split into
Engineering Oncolytic Viruses
Wild-Type Oncolytic Viruses
Market segment by Application, split into
Hospitals
Clinics
Ambulatory Surgical Centers

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America